ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 161 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $221,092 | -58.9% | 6,200 | -70.8% | 0.00% | -87.5% |
| Q1 2023 | $538,480 | +63.9% | 21,200 | +161.7% | 0.01% | +33.3% |
| Q4 2022 | $328,536 | +50.0% | 8,100 | +30.4% | 0.01% | 0.0% |
| Q2 2022 | $219,000 | -79.8% | 6,213 | -73.6% | 0.01% | -79.3% |
| Q1 2022 | $1,083,000 | +310.2% | 23,543 | +491.5% | 0.03% | +93.3% |
| Q1 2021 | $264,000 | -82.5% | 3,980 | -83.3% | 0.02% | -84.7% |
| Q4 2019 | $1,509,000 | +110.8% | 23,800 | -6.3% | 0.10% | +127.9% |
| Q3 2019 | $716,000 | +244.2% | 25,400 | +124.8% | 0.04% | +22.9% |
| Q1 2019 | $208,000 | +14.9% | 11,300 | +20.0% | 0.04% | -58.3% |
| Q3 2018 | $181,000 | – | 9,416 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |